CD63 and neoplasm: This demonstrates that TIMP-1 glycosylation is not necessary for the execution but rather for the modulation of the antiproteolytic activity of TIMP-1, while glycosylation was necessary to execute the tumor-promoting cytokine-like effects of TIMP-1 via CD63 (Figs. 3 and 4).